Ironwood Pharmaceuticals Inc. logo

Ironwood Pharmaceuticals Inc. (IRWD)

Market Open
1 Sep, 18:42
NASDAQ (NGS) NASDAQ (NGS)
$
4. 26
+0.01
+0.3247%
$
699.61M Market Cap
- P/E Ratio
- Div Yield
741,664 Volume
0.68 Eps
$ 4.25
Previous Close
Add Transaction
Day Range
4.18 4.32
Year Range
1.01 5.78
Want to track IRWD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Ironwood Pharmaceuticals Inc. (IRWD) Statistics

Valuation metrics

Market Cap 699.61M
Enterprise value 997.59M
Trailing P/E (ttm) 5.19
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 1.75
Price/Book (mrq) -4.22
Enterprise Value/Revenue 2.56
Enterprise Value/EBITDA 4.13

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.5M
Average volume (90 days) 2.11M

Price summary

52-Week low 1.01
52-Week high 5.78
Beta -
50-Day moving average 4.05
200-Day moving average 3.88

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1,194:1,000
Last split Date 2 Apr 2019

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0.33%
Operating margin 0.61%

Operational effectiveness

Return on assets 0.46%
Return on equity -0.57%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 2.35
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.78
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 0.48
Total debt (mrq) -
Total Debt/Equity (mrq) -2.45
Current ratio (mrq) 6.06%
Book value per share (mrq) -0.98

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -